OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
53
Results
Show all
Save search
Copy query
Show results for
Unknown
(53)
Publication Date
Release Date
2021
(13)
2023
(8)
2022
(8)
2020
(5)
2018
(4)
2024
(3)
2019
(2)
2017
(2)
2015
(2)
2014
(2)
2025
(1)
2013
(1)
2012
(1)
2011
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Glycation changes molecular organization and charge distribution in type I collagen fibrils.
Not available
S-EPMC7042214
|
biostudies-literature
Cite
Poly(ADP-Ribose) Links the DNA Damage Response and Biomineralization.
Not available
S-EPMC6581741
|
biostudies-literature
Cite
Genome sequencing and comprehensive rare-variant analysis of 465 families with neurodevelopmental disorders.
Not available
S-EPMC10432178
|
biostudies-literature
Cite
De Novo VPS4A Mutations Cause Multisystem Disease with Abnormal Neurodevelopment.
Not available
S-EPMC7820634
|
biostudies-literature
Cite
MED27, SLC6A7, and MPPE1 Variants in a Complex Neurodevelopmental Disorder with Severe Dystonia.
Not available
S-EPMC9796674
|
biostudies-literature
Cite
Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa.
Not available
S-EPMC8360544
|
biostudies-literature
Cite
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.
Not available
S-EPMC9857594
|
biostudies-literature
Cite
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC8941448
|
biostudies-literature
Cite
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC10326520
|
biostudies-literature
Cite
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Not available
S-EPMC4159618
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets